Screening and quantitative determination of drugs of abuse in diluted urine by UPLC-MS/MS

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 947-948, Issue , 2014, Pages 83-95

  Hegstad, Solfrid ^a   Hermansson, Sigurd ^b   Betnér, Ingvar ^b   Spigset, Olav ^a,c   Falch, Berit Margrethe Hasle ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b WATERS CORPORATION   (United States)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Benzodiazepines; Central nervous system stimulants; Drugs of abuse; Opioids; Screening; UPLC MS MS

Indexed keywords

DRUG PRODUCTS; METABOLITES; NEUROPHYSIOLOGY; SCREENING;

BENZODIAZEPINES; CENTRAL NERVOUS SYSTEMS; DRUGS OF ABUSE; OPIOIDS; UPLC-MS/MS;

CHEMICAL ANALYSIS;

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALPRAZOLAM; AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CANNABIS; CENTRAL STIMULANT AGENT; CODEINE; DESVENLAFAXINE; EPHEDRINE; ETHYLMORPHINE; FENTANYL; HYDROMORPHONE; KETAMINE; METHADONE; METHAMPHETAMINE; MORPHINE; NORCLOMIPRAMINE; NORCODEINE; NORFLUNITRAZEPAM; OPIATE; OXAZEPAM; OXYCODONE; PETHIDINE; PREGABALIN; RITALINIC ACID; TRAMADOL; ZOLPIDEM; ZOPICLONE;

ARTICLE; CALIBRATION; DILUTION; DRUG ABUSE; DRUG DETERMINATION; DRUG SCREENING; DRUG URINE LEVEL; FALSE NEGATIVE RESULT; HIGH THROUGHPUT SCREENING; HUMAN; HYDROLYSIS; KIDNEY CONCENTRATING CAPACITY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; METABOLITE; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; URINE;

BENZODIAZEPINES; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUGS OF ABUSE; OPIOIDS; SCREENING; UPLC-MS/MS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; TANDEM MASS SPECTROMETRY;

EID: 84891955149     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2013.12.014     Document Type: Article

References (34)

1. Peters F.T. Clin. Biochem. 2011, 44:54.
2. Maurer H.H. Ther. Drug Monit. 2010, 32:324.
3. Pitt J.J. Clin. Biochem. Rev. 2009, 30:19.
4. de Jager A.D., Bailey N.L. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2011, 879:2642.
5. Yuan C., Heideloff C., Kozak M., Wang S. Clin. Chem. Lab. Med. 2012, 50:95.
6. Gustavsson E., Andersson M., Stephanson N., Beck O. J. Mass Spectrom. 2007, 42:881.
7. Van De Steene J.C., Lambert W.E. J. Am. Soc. Mass Spectrom. 2008, 19:713.
8. Peters F.T., Remane D. Anal. Bioanal. Chem. 2012, 403:2155.
9. Thorngren J.O., Ostervall F., Garle M. J. Mass Spectrom. 2008, 43:980.
10. Eichhorst J.C., Etter M.L., Rousseaux N., Lehotay D.C. Clin. Biochem. 2009, 42:1531.
11. Al-Saffar Y., Stephanson N.N., Beck O. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2013, 930:112.
12. Thieme D., Sachs H., Thevis M. J. Mass Spectrom. 2008, 43:974.
13. Stephanson N., Dahl H., Helander A., Beck O. Ther. Drug Monit. 2002, 24:645.
14. Chebbah C., Pozo O.J., Deventer K., Van Eenoo P., Delbeke F.T. Rapid Commun. Mass Spectrom. 2010, 24:1133.
15. Wang P., Stone J.A., Chen K.H., Gross S.F., Haller C.A., Wu A.H. J. Anal. Toxicol. 2006, 30:570.
16. Duer W.C., McFarland S. J. Anal. Toxicol. 2007, 31:419.
17. Fu S., Lewis J., Wang H., Keegan J., Dawson M. J. Anal. Toxicol. 2010, 34:243.
18. Hackett L.P., Dusci L.J., Ilett K.F., Chiswell G.M. Ther. Drug Monit. 2002, 24:652.
19. Svensson J.O., Andersson M., Gustavsson E., Beck O. J. Anal. Toxicol. 2007, 31:81.
20. Shakleya D.M., Dams R., Choo R.E., Jones H., Huestis M.A. J. Anal. Toxicol. 2010, 34:17.
21. Westin A.A., Huestis M.A., Aarstad K., Spigset O. J. Anal. Toxicol. 2009, 33:610.
22. Huestis M.A., Cone E.J. J. Anal. Toxicol. 1998, 22:445.
23. Peters F.T., Drummer O.H., Musshoff F. Forensic Sci. Int. 2007, 165:216.
24. Guidance for industry Bioanalytical Method Validation May 2001, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf.
25. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Anal. Chem. 2003, 75:3019.
26. Bagoien G., Morken G., Zahlsen K., Aamo T., Spigset O. J. Clin. Psychopharmacol. 2009, 29:248.
27. Meatherall R. J. Anal. Toxicol. 1994, 18:382.
28. Hegstad S., Oiestad E.L., Johansen U., Christophersen A.S. J. Anal. Toxicol. 2006, 30:31.
29. Wohlfarth A., Toepfner N., Hermanns-Clausen M., Auwarter V. Anal. Bioanal. Chem. 2011, 400:737.
30. Forsman M., Nystrom I., Roman M., Berglund L., Ahlner J., Kronstrand R. J. Anal. Toxicol. 2009, 33:491.
31. Golding Fraga S., Diaz-Flores Estevez J., Diaz Romero C. Ann. Clin. Lab. Sci. 1998, 28:160.
32. Moody D.E., Monti K.M., Spanbauer A.C. J. Anal. Toxicol. 1999, 23:535.
33. Jamerson M.H., McCue J.J., Klette K.L. J. Anal. Toxicol. 2005, 29:627.
34. Berg T., Lundanes E., Christophersen A.S., Strand D.H. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2009, 877:421.